Lyme Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate
Saint-Herblain (France) and New York, February 4, 2022– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive Phase 2 data for their Lyme disease vaccine... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 4, 2022 Category: Pharmaceuticals Source Type: clinical trials

Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
Conditions:   Post Treatment Lyme Syndrome;   Chronic Pain;   Central Sensitization Interventions:   Drug: Milnacipran with D-cycloserine augmentation;   Drug: Milnacipran with placebo augmentation Sponsor:   Research Foundation for Mental Hygiene, Inc. Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2021 Category: Research Source Type: clinical trials